SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-19-008087
Filing Date
2019-02-14
Accepted
2019-02-14 16:01:47
Documents
3
Group Members
DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv512976_sc13ga.htm SC 13G/A 45093
2 EXHIBIT 1 tv512976_ex-1.htm EX-99.1 6481
3 EXHIBIT 2 tv512976_ex-2.htm EX-99.2 4233
  Complete submission text file 0001144204-19-008087.txt   57472
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

IRS No.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1228
Type: SC 13G/A | Act: 34 | File No.: 005-87833 | Film No.: 19605871
SIC: 2834 Pharmaceutical Preparations